Endocard India Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.00 M
- Company Age 26 Year,
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.31 Cr
- Satisfied Charges ₹ 1.11 Cr
- Revenue Growth -21.65%
- Profit Growth -13.22%
- Ebitda 41.64%
- Net Worth 5.12%
- Total Assets 8.68%
About Endocard India
Endocard India Private Limited (EIPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 February 1999 and has a history of 26 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹4.31 Cr. The company has closed loans amounting to ₹1.11 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajiv Khurana and Shakuntla Devi serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239DL1999PTC098174
-
Company No.
098174
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Feb 1999
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Endocard India Private Limited offer?
Endocard India Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Syringes, Nutraceuticals & Dietary Supplements, Nutraceuticals, Health Conditions, Cold & Cough, Mental Wellness, Vitamins & Supplements, Mineral Supplements.
Who are the key members and board of directors at Endocard India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Khurana
|
Director | 01-Feb-1999 | Current |
|
Shakuntla Devi
|
Director | 01-Feb-1999 | Current |
Financial Performance of Endocard India.
Endocard India Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 21.65% decrease. The company also saw a substantial fall in profitability, with a 13.22% decrease in profit. The company's net worth moved up by a moderate rise of 5.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Endocard India?
In 2021, Endocard India had a promoter holding of 75.67% and a public holding of 24.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
C And C Organics Private LimitedRajiv Khurana is a mutual person
-
C&C Healthcares Private LimitedRajiv Khurana is a mutual person
Charges (Loans)
₹43.10 M
₹11.10 M
Charges Breakdown by Lending Institutions
- Others : 3.80 Cr
- Citi Bank Na : 0.51 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2012 | Others | ₹3.80 Cr | Open |
| 31 Mar 2011 | Citi Bank Na | ₹5.10 M | Open |
| 22 Mar 2016 | Others | ₹7.50 M | Satisfied |
| 16 Jul 2009 | Icici Home Finance Company Limited | ₹3.60 M | Satisfied |
How Many Employees Work at Endocard India?
Endocard India has a workforce of 12 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Endocard India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Endocard India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.